ArriVent Announces Pricing of Upsized Initial Public OfferingGlobe Newswire • 4 months agoNEWTOWN SQUARE, Pa., Jan. 25, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. ( ArriVent ) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative...